Epsilogen
Niki Faulkner is a skilled research scientist currently employed at Epsilogen Ltd since January 2024. Previously, Niki held the position of scientist at BiVictriX Therapeutics plc from October 2022 to January 2024, leading investigations on novel cancer biomarkers and specializing in flow cytometry. Experience as a graduate teaching assistant at Imperial College London from October 2018 to October 2022 included lab practical assistance and lecturing on the MSc Genes, Drugs & Stem Cells course. Niki completed a PhD in the G. Kassiotis lab at The Francis Crick Institute from September 2017 to October 2022 and served as a chemistry tutor at Lanterna Education. Niki's academic background includes an MBiochem in Biochemistry from the University of Oxford, complemented by various research and teaching roles across notable institutions.
This person is not in any teams
This person is not in any offices
Epsilogen
1 followers
Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life.